SARS-CoV-2 Spike S1 antibody (Biotin) Primary Antibody
Reactivity: SARS Coronavirus-2 (SARS-CoV-2) ELISA Host: Human Monoclonal H6
Catalog No. ABIN6953155
Plus shipping costs $45.00
local_shipping Shipping to: United States
Delivery in 11 to 14 Business Days
- Antibody Type
- Recombinant Antibody
- SARS Coronavirus-2 (SARS-CoV-2)
- This SARS-CoV-2 Spike S1 antibody is conjugated to Biotin
- Recombinant anti-SARS-CoV-2 spike Mouse ScFv is expressed from 293 cells (HEK293) with a human IgG1 Fc tag on C-terminal.
Mouse scFv fusion with human IgG1 Fc
- Recombinant Human Novel Coronavirus Spike glycoprotein (S) (16-685aa)
- scFv fragment
- Discover our best selling SARS-CoV-2 Spike S1 Primary Antibody
- Application Notes
- Optimal working dilution should be determined by the investigator.
- For Research Use only
- 50 % Glycerol, 0.01M PBS, pH 7.4, 0.03 % Proclin 300
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- -20 °C,-80 °C
- Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze
- Spike glycoprotein comprises two functional subunits responsible for binding to the host cell receptor (S1 subunit) and fusion of the viral and cellular membranes (S2 subunit). For many coronavirus (CoVs), S is cleaved at the boundary between the S1 and S2 subunits, which remain non-covalently bound in the prefusion conformation. The distal S1 subunit comprises the receptor-binding domain(s) and contributes to stabilization of the prefusion state of the membrane-anchored S2 subunit that contains the fusion machinery. S is further cleaved by host proteases at the so-called S2' site located immediately upstream of the fusion peptide in all CoVs. This cleavage has been proposed to activate the protein for membrane fusion via extensive irreversible conformational changes. However, different CoVs use distinct domains within the S1 subunit to recognize a variety of attachment and entry receptors, depending on the viral species. Endemic human coronaviruses OC43 and HKU1 attach via their S domain A to 5-N-acetyl-9-O-acetyl-sialosides found on glycoproteins and glycolipids at the host cell surface to enable entry into susceptible cells. MERS-CoV S uses domain A to recognize non-acetylated sialoside attachment receptors, which likely promote subsequent binding of domain B to the entry receptor, dipeptidyl-peptidase 4. SARS-CoV and several SARS-related coronaviruses (SARSr-CoV) interact directly with angiotensin-converting enzyme 2 (ACE2) via SB to enter target cells.
- Gene ID
You are here: